Cancer & Infectious Disease Flashcards
(43 cards)
Carcinoma in situ
cells have lost architecture completely and leave normal space to invade other organs
Oncogene
- gain of function mutation
- ras, Myc
Tumor suppressor gene
Loss of function promotes tumors
Tumor suppressor gene
Loss of function promotes tumors
- Inhibits cell prolif or protects genome
ex. p53, pRB
Hallmark - self sufficiency in growth signals
- Gene expression of receptor over amplified, sometimes more copies of receptor on chromosome
- Oncogenic activation of downstream signalling pathway
Hallmark - self sufficiency in growth signals
- Gene expression of receptor over amplified, sometimes more copies of receptor on chromosome
- Oncogenic activation of downstream signalling pathway
- Ras, Raf/MAPK, PI3K - Paracrine to autocrine transition
- Blocking of receptor endocytosis
HER-2
- Human EGF Receptor
- Breast cancer
Herceptin
- EGFR inhibitor
- Monoclonal Ab that recognizes HER2 extracellular domain
- Doesn’t distinguish b/w normal HER2 (necessary for life) and cancerous HER2, dose dependent
Tarceva
- EGFR inhibitor
- Approved for late stage pancreatic cancer and non-small cell lung cancer
- Enters cells
- Competes w/ ATP for binding to RTK kinase domain –> blocks kinase activity
Hallmark - Insensitivity to anti-growth signals
- TGF-beta, via Rb, blocks G1-Cdk and helps keep cells in quiescent state (G0)
- G1 Cdk/cyclin active –> phosphorylate/inactivate Rb –> E2f tx factor active –>S phase entry
- Mut of Rb –> loss of function
- Viral prot inactivates Rb (ex. HPV)
- Down regulate or mutate TGF-beta pathway
Hallmark - Evasion of apoptosis
- Mutate p53 ‘guardian of genome’ (DNA damage control)
- Allows accumulation of DNA damage
Hallmark - Limitless replicative potential
- Telomeres: repeated DNA seq at end of chromo that prevent fusions and other instability
- Terminal repeat not replicated during simple DNA replication = shortened w each cell division –> sensed by p53 pathway as DNA damage –> senescence
- Tumor cells express telomerase, prevent telomere loss –> immortalization
Hallmark - tissue invasion and metastasis
- Invasion requires actin cytoskeleton
- Rho C –> actomyosin contractility
Hallmark - Sustained angiogenesis
- Hypoxic cells produce VEGF (vascular endothelial growth factor) to recruit new blood vessels
- Most tumors cannot grow until under go ‘angiogenic switch’ to produce VEGF
- Angiogenesis inhibitors –> Avastin
Mass effect
Tumor growth blocks/compresses vital organ
Erosion/ulceration of resident organ
- leads to infection of blood vessels –> anemia
- Local interactions b/w tumor and microenvironment
- Invasion, stromal signalling, angiogenesis
Paraneoplastic syndromes
- Hypercalcemia
- Hypercoaguability,
- Cancer cachexia
- Tumor induced wasting syndrome
- > 50% of cancer patients
- ~20% of cancer deaths
- Tissues and physiology FAR from tumor site are pathologically perturbed by secretion of humoral factors (hormones/cytokines) that promote immune response
Passenger and driver mutations
- Most are harmless mutations
- Environment can induce additional mutations
- Driver mutations contribute to cell proliferation
- Repair pathway can be mutated, increasing rate of mutations
- Cells can evolve resistance to chemotherapy
Chromothripsis
- Tens to hundred of genomic rearrangements occur in a one-off cellular crisis
- 2-3% of all cancers
- 255 of bone cancers
Mis-segregation
Extra chromo can propagate as micronuclei
Carcinoma
Epithelial cells
-Cover external and internal body surfaces (90%)
Sarcoma
- Supporting tissue
- Bone, cartilage, fat, connective tissue, pancreas, liver
Lymphoma and leukemia
-blood and lymphatic tissue
Normal cell proliferation
- Anchorage dependent
- Density-dependent inhibition
- Limited number of cell divisions
- Telomere shortening
- Proliferation dependent on extracellular signals
- Checkpoints activated at appropriate times
- Apoptosis functional